Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
일요일, 9월 06

DaVita Inc

DVANYSE
Trade with Public
Trade with Public
$183.99
2.331.28%
가까이에: Sep 4, 5:00 PM EST
$183.99
N/A
시간외: Sep 4, 4:00 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

DaVita Financials

DaVita (DVA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
DaVita Affirms FY2026 Adj EPS Guidance of $14.10-$15.20 vs $14.82 Est

DaVita (NYSE:DVA) affirms FY2026 Adj EPS guidance from $14.10-$15.20 to $14.10-$15.20 vs $14.82 analyst estimate..
Benzinga Newsdesk

PRO
DaVita Q2 Adj. EPS $4.02 Beats $3.88 Estimate, Sales $3.554B Beat $3.496B Estimate

DaVita (NYSE:DVA) reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $3.88 by 3.61 percent. This is a 36.27 percent increase over earnings of $2.95 per share from the same period
Benzinga Newsdesk

PRO
DaVita Raises FY2026 Adj EPS Guidance from $13.60-$15.00 to $14.10-$15.20 vs $13.98 Est

DaVita (NYSE:DVA) raises FY2026 Adj EPS guidance from $13.60-$15.00 to $14.10-$15.20 vs $13.98 analyst estimate..
Benzinga Newsdesk

PRO
DaVita Q1 Adj. EPS $2.87 Beats $2.32 Estimate, Sales $3.416B Beat $3.356B Estimate

DaVita (NYSE:DVA) reported quarterly earnings of $2.87 per share which beat the analyst consensus estimate of $2.32 by 23.71 percent. This is a 43.5 percent increase over earnings of $2.00 per share from the same period
Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

DaVita Stock Rallies On Profit Beat, Confident 2026 View

DaVita stock surged after the kidney care provider beat earnings estimates and issued strong 2026 guidance, signaling stable treatment volumes, higher reimbursement rates, and an improving income outlook.
Vandana Singh

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved